as on November 28, 2025 at 11:29 pm IST
Day's Low
Day's High
2.94%
Downside
3.83%
Upside
52 Week's Low
52 Week's High
85.90%
Downside
3.80%
Upside
Check Phathom Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
-2.4075
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-212.8M
Revenue (TTM)
147.2M
Profit Margin
-186.53%
Return On Equity TTM
-3489.00%
Compare market cap, revenue, PE, and other key metrics of Phathom Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | -63.78% | NA | -186.53% | |
| BUY | $44.3B | 422.04% | -16.34 | -264.83% | |
| BUY | $58.8B | 247.47% | 1435.87 | 1.36% | |
| BUY | $110.8B | 91.26% | 30.39 | 31.35% | |
| BUY | $83.2B | 51.77% | 18.8 | 32.13% |
The Phathom Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Phathom Pharmaceuticals Inc investment value today
Current value as on today
₹1,82,416
Returns
₹82,416
(+82.42%)
Returns from Phathom Pharmaceuticals Inc Stock
₹76,663 (+76.66%)
Dollar Returns*
₹5,753 (+5.75%)
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Phathom Pharmaceuticals Inc. Average target price of $23.12
Get share price movements and forecasts by analysts on Phathom Pharmaceuticals Inc.
What analysts predicted
32.22%UPSIDE
Target Price
$23.12
Current Price
$15.67
Analyzed by
14 Analysts
Target
$23.12
Phathom Pharmaceuticals Inc target price $23.12, a slight upside of 32.22% compared to current price of $15.67. According to 14 analysts rating.
Search interest for Phathom Pharmaceuticals Inc Stock has decreased by -30% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, PHAT stock has moved up by 15.4%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 1047.3% return, outperforming this stock by 979.9%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 176.4% return, outperforming this stock by 100.3%
| Organisation | Phathom Pharmaceuticals Inc |
| Headquarters | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
| Industry | Health Technology |
| CEO | Mr. Steven L. Basta M.B.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. David A. Socks | Co-Founder |
Mr. Steven L. Basta M.B.A. | CEO, President & Director |
Ms. Anne Marie Cook Esq., J.D. | Chief Legal Officer & Corporate Secretary |
Ms. Nancy R. Phelan | Senior Vice President of Marketing & Analytics |
Dr. Azmi Nabulsi M.D., M.P.H. | Co-Founder |
Mr. Sanjeev Narula | Chief Financial & Business Officer |
Mr. Jonathan Bentley | Senior VP and Head of Sales, Operations & Training |
Mr. Robert Breedlove | VP of Finance & Principal Accounting Officer |
Mr. Eric Sciorilli | Director of Business Development & Investor Relations |
Mr. Bill Aprea J.D. | Senior VP, Chief Compliance Officer & Deputy Chief Legal Officer |
Phathom Pharmaceuticals Inc share price today is $15.67 as on at the close of the market. Phathom Pharmaceuticals Inc share today touched a day high of $16.27 and a low of $15.21.
Phathom Pharmaceuticals Inc share touched a 52 week high of $16.27 on and a 52 week low of $2.21 on . Phathom Pharmaceuticals Inc stock price today i.e. is closed at $15.67,which is 3.66% down from its 52 week high and 609.05% up from its 52 week low.
Phathom Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Phathom Pharmaceuticals Inc (PHAT) shares with as little as ₹89.332 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹893.32 in Phathom Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Phathom Pharmaceuticals Inc share’s latest price of $15.67 as on November 28, 2025 at 11:29 pm IST, you will get 0.6382 shares of Phathom Pharmaceuticals Inc. Learn more about
fractional shares .
Phathom Pharmaceuticals Inc stock has given -63.78% share price returns and 20.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?